1 reports of this reaction
4.2% of all Trelegy reports
#7 most reported adverse reaction
BILIARY COLIC is the #7 most commonly reported adverse reaction for Trelegy, manufactured by Aurobindo Pharma Limited. There are 1 FDA adverse event reports linking Trelegy to BILIARY COLIC. This represents approximately 4.2% of all 24 adverse event reports for this drug.
Patients taking Trelegy who experience biliary colic should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BILIARY COLIC is moderately reported among Trelegy users, representing a notable but not dominant share of adverse events.
In addition to biliary colic, the following adverse reactions have been reported for Trelegy:
BILIARY COLIC has been reported as an adverse event in 1 FDA reports for Trelegy. This does not prove causation, but indicates an association observed in post-market surveillance data.
BILIARY COLIC accounts for approximately 4.2% of all adverse event reports for Trelegy, making it a notable side effect.
If you experience biliary colic while taking Trelegy, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.